On 23rd August, the signing and unveiling ceremony of "Sino-German Cooperation - Working Together to Build a Medical Highland in the West" was held at Chongqing Kangxin Hospital. Liao Guanghong, Vice Mayor of Jiangbei District Government, Liao Qingping, Deputy Secretary of Party Committee of Jiangbei District Health Committee, Wolfgang Rudischhauser, Consul General of German Consulate General in Chengdu, Paul Devlin, Authorized Representative of German Artemed Medical Group, Du Qiang, Co-Founder of Silver Mountain Group and Hao Geng, President of Board of Directors of Kangxin Group, as well as other leaders and guests attended the ceremony.

 

(Signing Ceremony)

 

A four-way signing ceremony was held by Chongqing Kangxin Hospital, Artemed Hospital (Germany), Silver Mountain Group and Kanghua Medical Group to formally establish a strategic cooperation. This will involve multi-dimensional cooperation in the field of healthcare. Furthermore, Artemed Hospital has awarded Chongqing Kangxin Hospital a license to become its partner hospital. As one of Europe's leading hospitals, Artemed Hospital will be delivering the most advanced cardiovascular diagnostic and treatment technology and management system to Chongqing Kangxin Hospital, thus ensuring that it meets international hospital standards. Professor Ma Changsheng, the Chairman-designate of the Cardiovascular Disease Branch of the Chinese Medical Association and the director of the National Clinical Cardiovascular Disease Research Centre, was formally appointed as the chief cardiology expert of the hospital.

 

(Unveiling Ceremony)

 

(Certificate Issuance)

 

At the meeting, Liao Guanghong, Mayor of Jiangbei District Government, made the following statement in his speech: "Chongqing Kangxin Hospital, as one of the key components of Jiangbei District's healthcare infrastructure, has not only persisted in its contributions to the efforts against the pandemic, but also occupies a leading position in the field of cardiovascular disease diagnosis and treatment." Jiangbei District is committed to supporting the development of healthcare and health initiatives in the region. The recent collaboration between Chongqing Kangxin Hospital and Artemed Hospital from Germany is a significant step in this direction. The district aims to contribute to the growth of Chongqing as a leading medical city and a prominent healthcare provider in the western region of China. This commitment aligns with the national initiative of 'Healthy China'.

 

(Liao Guanghong, Mayor of Jiangbei District Government)

 

Wolfgang Rudischhauser, Consul General of the German Consulate General in Chengdu, introduced the project: "This is the second lighthouse project in the field of healthcare cooperation under the framework of the Sino-German Cooperation Platform for Action, signed by then-German Chancellor Angela Merkel in 2014. (Chongqing Kangxin Hospital has become the partner hospital of the German hospital Artemed)." In collaboration with the 17 hospitals of Artemed Hospital in Germany, Chongqing Kangxin Hospital is poised to serve as a model for German-Chinese cooperation across all six domains of healthcare, as outlined in the aforementioned action programme for cooperation and knowledge sharing. At the same time, he mentioned that the DRGs model in China's healthcare reform is already being used at Artemed Hospital, which is why German Artemed Hospital has received special attention from the Chinese government. Consul General Lu Wugang added that he believes there is much to be gained from mutual learning.

 

(Wolfgang Rudischhauser, Consul General of the Consulate General of Germany in Chengdu)

 

Rainer Salfeld, Chairman of the Board of Directors of Artemed Hospital Group (Artemed SE), Germany, sent a video from the site, 'Due to the epidemic, we were unable to come to China and could only attend via video conference; Chongqing Kangxin Hospital & Artemed’s partner hospitals in Germany will be focusing on best practices, quality of care and healthcare innovation. At the same time, we hope that our new colleagues will be able to share their expertise in Chinese medicine.'

 

(Rainer Salfeld, Chairman of Artemed SE, Artemed Hospital Group, Germany)

 

Du Qiang, co-founder of Silver Mountain Group, spoke at the meeting. “We are committed to establishing an integrated position encompassing 'medical education, research and production', with a gradual reliance on Chongqing's biological laboratories to conduct translational medicine and evolve into a teaching hospital for the medical school of a prestigious university. We are dedicated to leveraging the advanced expertise of the Artemed Group of Germany in hospital management, infectious diseases and other domains for the benefit of Chongqing, contributing to the field of medical innovation with the backing of the Chinese and German governments. ” Finally, he expressed his sincere thanks to the Chongqing Municipal Government, the German Consulate in China, the Chongqing Municipal Health Commission, the Chongqing Foreign Affairs Office, and the leaders of the Jiangbei District for their support of the project.

 

(Du Qiang, co-founder of Silver Mountain Group)

 

Hao Geng, President of Kanghua Group, presented an overview of the development of Chongqing Kangxin Hospital. He highlighted the hospital's potential to meet high expectations in its new location and its commitment to making significant contributions to cardiovascular health in Chongqing and China as a whole.

 

(Hao Geng, President of Kanghua Group, Kanghua Group)

 

This afternoon, the second 'Chongqing Kangxin Cardiovascular Disease Forum' was held at the hospital. The event brought together numerous experts from the domestic cardiovascular medical and surgical sectors. Through a combination of online and offline channels, the forum facilitated discussions and knowledge sharing on current issues in the cardiovascular field.

 

 

Chongqing Kangxin Hospital, a medical institution under the Guangdong Kanghua Medical Group, established itself in Chongqing in 2017, leveraging the momentum of 'Yu Qia Hui' and becoming the first tertiary specialist hospital for cardiovascular disease in the region. Following a period of five years' development, Chongqing Kangxin Hospital has become one of a select number of hospitals in Chongqing capable of performing a range of cardiac surgeries. In the future, the hospital will offer cutting-edge technologies, including robotic cardiac surgery, coronary artery bypass grafting + PCI hybrid surgery, various interventional valve technologies, and one-stop atrial fibrillation ablation blocking surgery.

 

With the support of Silver Mountain Group, Chongqing Kangxin Hospital has become the second Sino-German cooperative hospital of the German Artemed Hospital Group (Artemed) to open in China. The hospital has received strong support and focused attention from the German Ministry of Health. The German Ministry of Health commissioned the German-Chinese Medical Association to liaise with China's National Health Commission to support the inclusion of this project in the Action Plan for Sino-German Healthcare Cooperation and to become the second landmark hospital project under the plan. The next step will be to proactively investigate the DRGs pilot hospital, dual-track payment, approvals for oncology drug application and GCP qualification. The objective is to develop Chongqing Kangxin Hospital into a research-oriented international hospital integrating 'medicine, education, research and production'. The aim is to contribute to the establishment of Chongqing as a medical highland in the west of China. Thereby contributing to the construction of Chongqing as a medical highland in the west.

Silver Mountain Group (“SMG”) and Shanghai Jiushi Real Estate Co., Ltd. (“Jiushi Real Estate”) officially signed a strategic cooperation agreement on June 18, 2021. This collaboration aims to enable deep cooperation between both parties in modern service industries such as culture & art, medical care services and health management.

 

Founded in 1993 as the wholly-owned subsidiary of Shanghai Jiushi Group Co., Ltd. (“Jiushi Group”), Jiushi Real Estate absorbed Shanghai Johnson & Johnson Group in 2013 and now owns 11 wholly-owned and holding companies. Among the four business sectors of Jiushi Group, Jiushi Real Estate engages in the real estate sector. It has formed a comprehensive real estate industry chain with the business domain covering land reservation, real estate development, rental and property management. Jiushi Real Estate is also entrusted with the operation and management of 16 cultural relics and protected buildings owned by Jiushi Group in the core area of the Bund.

 

 

Allocating resources on the basis of urban planning and functional zone division of the selected area (including, but not limited to, the Bund in Shanghai and subsidiary property management companies of Jiushi Real Estate), SMG and Jiushi Real Estate plan to enable Shanghai to build a top central active area and a model demonstration area with both innovation and lean management of mega-cities. The two parties are committed to promote new business forms for business innovation and to introduce industrial resource recognized by both parties such as culture & art, medical care service and health management to planned projects in order to enhance their commercial value and social influence, and at the same time to improve the industry level for the project site to attract high-end talents.
Through sincere cooperation, the two parties hope that the cooperative projects they planned can play an active role in promoting multilateral cooperation and exchanges in the backdrop of an increasingly complex international context.

 The signing ceremony of the Weihai Artemed International Hospital and Biomedical Union-Lab was held on February 26 2021. Administrative Committee of Weihai ETD Zone, Hong Kong Chenda Holding Group and Silver Mountain Group (“SMG”) attend the ceremony.

Wang Qing, deputy secretary and deputy director of the District Committee of Work, said that the Weihai ETD has unique geographical advantages and incomparable ecological environment. As a new highland for innovation and entrepreneurship, a demonstrative district of exquisite city, the ETD Zone is vigorously fostering the development of medical, health and technology R&D with a more open attitude to create a dynamic and vigorous city.

Hong Kong Chenda Holding Group is a comprehensive enterprise led by innovative industries. Chairman Zou Jianmin actively responded to the call of "Healthy China" and returned to her hometown Weihai to help the development of healthcare industry of this city. The German Artemed SE is a leading German institution in medical service and geriatric care. SMG is a China-focused project development and fund management company which has established in-depth cooperative relationships with the world's top medical institutions by extensive resource network and outstanding resource integration capabilities in the field of medical and health care. The ETD Zone attaches great importance to the cooperation with these three outstanding enterprises. After a year and a half, 10 mutual visits, face-to-face consultations and more than 20 discussions, a consensus on cooperation and implementation path had been reached. It will open a new chapter of in-depth cooperation and win-win development based on the principle of mutual benefit by playing of respective advantages to promote the construction and operation of the project. The ETD Zone Weihai will strive to provide a business environment with the best policies, services and the highest efficiency, do its utmost to support project construction and enterprise development to create a better future.

 

Silver Mountain Group (“SMG”) and Siemens Healthineers have formed a strategic partnership in March 2021. This collaboration is a long-term Value Partnership. This partnership model with Siemens Healthineers enables healthcare providers to optimize business processes, expand capabilities, and advance innovation.

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalising healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics.

SMG was founded in Hong Kong in 2013 by a European family to capture opportunities in China. Since the establishment, SMG has been focusing on building a health care ecosystem integrating medical service, medical research and medical education. SMG got closed-loop development by project incubation, investment and operation with rich healthcare investment experience and strong project management competency, as well as trusted partnership with enterprises, institutions, agencies and universities home and abroad. Thanks to this strong global network and the international elite team, SMG could keep competitive and take the lead in the industry.

The partnership with Siemens Healthineers is known as a “Value Partnership”. It’s a long-term partnership that enables healthcare providers to enhance their enterprise value and reduce operating complexity. Both parties will participate in China’s healthcare and medical technology industries and strive to set industry benchmarks by integrating resources, expertise and experience to jointly promote, medical service technology, medical equipment and digital medical technology. Through the sincere cooperation, world-class healthcare projects and industrial operation models that are in line with China’s national conditions will be established.

 

The local-made Tesla rolled off the assembly line at the end of the year, and China's first foreign-funded comprehensive hospital officially opened. As China's earliest listed free trade zone, the Shanghai Free Trade Zone announced on Sep 26th 2019 the latest developments in two major benchmarking projects.

"Shanghai Free Trade Zone Lingang New Area is Tesla's "Dream City"." said Tao Lin, Tesla's global vice president. Tesla completed factory construction, equipment installation and commissioning in less than one year.

The opening up is not only shown in advanced manufacturing industry but also modern service industry. The first foreign owned comprehensive hospital in the Shanghai Free Trade Zone, Shanghai International Hospital Project, announced its official opening after five years of construction on Sep 26.

As a well-known German medical brand, Artemed SE is one of the first batch foreign medical institutions to enter the Chinese market after the Shanghai Free Trade Zone opened its medical service industry to the outside world. Shanghai International Hospital Project is also one of the pilot cooperation projects in the 2014 “Sino-German Health Cooperation Action Plan”. The overall plan of Shanghai International Hospital Project is divided into two phases (500 beds). The first phase opened on 26th (200 beds), featuring orthopedics and oncology. "In Germany, about 200,000 people receive orthopedic surgery including joint replacement every year. We hope to bring such mature experience to China to promote medical exchanges between China and Germany." Prof. Dr. Rainer Salfeld, CEO of Artemed SE, said that thanks to the expansion of the free trade zone and the assistance of the Waigaoqiao Group, Shanghai International Hospital Project can successfully register and settle in Shanghai.

The expansion and opening up of the free trade zone mean more than just introducing one or two foreign investment projects. Through opening up, the free trade zone will promote China's domestic reforms and accelerate the integration of China's overall business environment with advanced international standards.

The signing ceremony of the Fifth Affiliated Hospital of Guangzhou Medical University - Hospital Clinic de Barcelona “Heart Center” is held on Nov 28, 2020 at the Fifth Affiliated Hospital of Guangzhou Medical University. As a key project led by Silver Mountain Group (“SMG”), this project is also the Phase 1 project of the Guangzhou Barcelona International Hospital which will be officially put into operation in March 2021.

Leaders, experts and scholars from Guangzhou Huangpu District, Guangzhou Development District, Silver Mountain Group and the Fifth Affiliated Hospital of Guangzhou Medical University attended the event.

Hospital Clinic de Barcelona is a leading European medical institution with a history of more than 100 years which completed the world's first fetal heart surgery. It ranked 21st on the World’s Best Hospital 2020 by Newsweek.
SMG was founded in Hong Kong in 2013 by a European family to capture opportunities in China. Since the establishment, SMG has been focusing on building a health care ecosystem integrating medical service, medical research and medical education. SMG got closed-loop development by project incubation, investment and operation with rich healthcare investment experience and strong project management competency, as well as trusted partnership with enterprises, institutions, agencies and universities home and abroad. Thanks to this strong global network and the international elite team, SMG could keep competitive and take the lead in the industry.

Guangzhou Barcelona International Hospital and its Heart Center are key projects of SMG. This project is a depth cooperation with Hospital Clinic de Barcelona. Through the construction of the Heart Center, combined with the basis of the Department of Cardiovascular of the Fifth Affiliated Hospital of Guangzhou Medical University, it will be developed into a key representative discipline of the hospital and strive to become a provincial, municipal, national key research project and a demonstration for the implementation of innovative reform policies together with the localization and construction of Guangzhou Barcelona International Hospital.

On November 28, 2018, President Xi Jinping held talks with Spanish Prime Minister Pedro Sánchez in Madrid.

Pedro Sánchez said that it was the first visit by a Chinese President in the past 13 years. It was the 45th anniversary of the establishment of diplomatic relations between Spain and China which had great historical significance and would usher in a new era in Spain-China relations. The development of Spain-China relations is satisfactory. The two sides are not only important trading partners but also increase chances for cultural and educational exchanges. The Chinese in Spain have also made positive contributions to the development of the Spanish country and the friendship between Spain and China. Under the new area, Spain is willing to increase political mutual trust with China and expand exchanges and cooperation in various fields. The “Belt and Road” is an important initiative of historical significance, and Spain is willing to actively participate in the joint construction of the “Belt and Road”. Spain firmly supports multilateralism, shares a similar position with China in international affairs and is willing to maintain close communication and coordination with China to promote the healthy and stable development of EU-China relations.

After the talks, the leaders of the two countries jointly witnessed the signing of a number of bilateral cooperation documents, covering areas such as culture, economy, livelihood, advanced materials, telecommunications, third-party market cooperation, education and finance. (The Guangzhou Barcelona International Hospital established by Silver Mountain Group is one of the signed key projects).

The two sides issued the "Joint Statement of the People's Republic of China and the Kingdom of Spain on Strengthening the Comprehensive Strategic Partnership in the New Era."

Ding Xuexiang, Yang Jiechi, Wang Yi, He Lifeng and others participated in the above activities.

The Administrative Committee of Guangzhou Development District (“GDD”), Fresenius Group and Silver Mountain Group (“SMG”) signed a strategic cooperation agreement on Nov 2nd, 2018.

GDD is the 1st pilot area of the EU-China Regional Policy Cooperation. One of the topics of EU-China Regional Policy Cooperation is to introduce European companies to establish its cooperation in GDD, supported by China and EU.

Fresenius Group is a global healthcare group offering high-quality products and services for dialysis, hospitals, and outpatient treatment which includes four independently operated business segments: Fresenius Medical Care is the world leader in treating people with chronic kidney failure, the leading supplier of dialysis products such as dialysis machines and dialysis filters. Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, supplies essential drugs, clinical nutrition products, medical devices and services to help critically and chronically ill patients, Fresenius Helios is Europe’s largest private hospital operator while Fresenius Vamed plans, develops and manages healthcare facilities.

SMG was founded in Hong Kong in 2013 by a European family to capture opportunities in China. Since the establishment, SMG has been focusing on building a health care ecosystem integrating medical service, medical research and medical education. SMG got closed-loop development by project incubation, investment and operation with rich healthcare investment experience and strong project management competency, as well as trusted partnership with enterprises, institutions, agencies and universities home and abroad. Thanks to this strong global network and the international elite team, SMG could keep competitive and take the lead in the industry.

The cooperation will focus on hemodialysis service business at independent hemodialysis centers, kidney specialist hospitals and general hospitals. The signing of the agreement marks the further professionalization and international development of China's kidney dialysis industry. 

On 25 May 2018, Silver Mountain Group signed a Strategic Cooperation Agreement with Cognos International Group(COGNOS) from Germany, marking the start of a new era of international and professional medical cooperation. Mr. Du Qiang of Silver Mountain Group, Mr. Hermann Kögler, Chairman of the Supervisory Board of COGNOS Group, Dr Matthias Afting, Spokesman of the Board of Directors and President of COGNOS International, and Dr Holger Korte, President of COGNOS International attended the ceremony.

COGNOS International Group is a leading educational group in Germany, specializing in professional vocational training in healthcare and nursing. COGNOS focuses on cooperation with overseas companies, especially in Asia, with the aim of transferring advanced technology from Europe, America, and the rest of the world to the cooperating companies through education and training.

 

 

On 2nd February 2018, Silver Mountain Group signed a Strategic Cooperation Agreement with Guangzhou Development District Administrative Committee, St John's Innovation Centre of the University of Cambridge, CFCC Cambridge Limited and ET Capital Limited to cooperate in the investment, construction, operation, and management of the 'China Cambridge Innovation Park' in the Guangzhou Development District.

 

Guangzhou Development District (GDD) is one of the first pilot areas for Sino-European and Sino-Israeli cooperation. It is committed to further deepening economic exchanges and cooperation between China and Europe, and to introducing advanced international education, technology, management models, management experience and service experience.

 

The University of Cambridge is a world-class university. It comprises 31 autonomous colleges and 150 departments and institutes with 19,000 students, including 3,700 international students from 120 countries. The University fosters links between academia and business and has a global reputation for innovation.

 

St John's Innovation Centre was established primarily to accelerate the development of innovative businesses in the Cambridge Technology Cluster. It takes full advantage of the leading role of Cambridge's high-tech and knowledge-based start-ups in technology innovation decisions, R&D investment, research organization and the translation and commercialization of results.

 

CFCC Cambridge Ltd. is a company dedicated to promoting cooperation and exchanges between Chinese companies and organizations and relevant departments, schools, and enterprises of the University, especially in the field of scientific and technological research and development.

 

ET Capital UK Limited is a fund management company focused on the Cambridge University Science Park and has been involved in investing in many of the University's incubation projects.

 

Silver Mountain Group's collaboration with the four parties will involve vigorous promotion, establishment, and operation of Cambridge Innovation Park in China. The project is to be established in Guangzhou Development District as an 'incubator', 'accelerator' and industrialization park for high-tech projects. The aim is to create an international platform and base for cooperation, exchanges, innovation, incubation, and industrialization of high-tech financial enterprises, especially between China and Europe, China and the US, and China and Israel. The project will promote the development of innovative enterprises in the park, enhance the overall innovation atmosphere and strengthen cooperation, business development and the establishment of international technological innovation.

On 26th January 2018, Silver Mountain Group signed a Strategic Cooperation Agreement with Shanghai GE Healthcare Systems Trade and Development Co. Ltd (GE Healthcare) . Ms. Yiqi Chen, General Manager of GE Healthcare's Private Healthcare Business Unit in Greater China, attended the signing ceremony.

 

GE Healthcare is part of the GE Healthcare business group of General Electric (China) Co. Ltd, whose mission is to provide the world with innovative medical technologies and services that usher in a new era of healthcare. GE Healthcare has a wide range of expertise in medical imaging, information technology, medical diagnostics, patient monitoring systems, drug discovery and development, bio-pharmaceutical technologies, operational excellence, and total operational solutions. The expertise helps to consolidate better services at lower costs to more people around the world.

 

Silver Mountain Group and GE Healthcare have entered a strategic partnership, leveraging each other's strengths and shared vision. GE Healthcare brings a strong portfolio in medical equipment, process reengineering, technical training, academic exchanges, management consulting and healthcare information solutions. The two companies will collaborate extensively, focusing on medical equipment, process optimization, management consulting, marketing, medical information systems and telemedicine. This partnership aims to create medical hospitals that are aligned with the global needs of patients. We are pleased to announce our extensive cooperation in the joint construction of a research-oriented, modern, intelligent, user friendlyand information-based international hospital.

 

On 5th December 2017, Silver Mountain Group's hospital entered into a strategic cooperation agreement with Zimmer (Shanghai) Medical International Trading Co. Zimmer Ltd. Yongming Li, Director and General Manager of Zimmer Medical attended the signing ceremony.

 

Zimmer was founded in 1927 and is a world-renowned professional orthopedic company. It specializes in the production and sale of artificial joint prostheses, trauma products, patient care products, arthroscopes, and orthopedic power devices. It is a global leader in the design, R&D, and manufacturing of orthopedic reconstruction, trauma, and spine products.

 

The Hospital Clinic of Barcelona and the fifth Affiliated Hospital of Guangzhou Medical University, together with other partners, signed a framework agreement to establish the Guangzhou Barcelona International Hospital in Huangpu district on Sep. 5th, 2017. The first Sino-Spanish joint medical project in China.
 
The other partners include the administration of Huangpu district and Guangzhou Development District, Faculty of Medicine and Health Sciences of University of Barcelona, and Silver Mountain Capital.
 
The partners will also build one or two high-end Pantheon Clinics in Huangpu.

The new hospital and clinics will connect with foreign commercial insurances and serve both local residents and employees, including employees of more than 3,400 foreign-funded firms in the district.
 
Guangzhou Medical University and Faculty of Medicine and Health Sciences of University of Barcelona will cooperate in student training and research.
 
The Hospital Clinic of Barcelona is one of the best medical institutions in Spain in medical service, research and innovation, said Jose M Campistol, CEO of the hospital. "It's a good opportunity to have an international project here in Guangzhou."
 
The details of the new hospital are expected to be worked out in the next six months and it is expected to open in about three years, with 400 beds, Campistol said.
 
The cooperation should enhance the international profile of Guangzhou Medical University, the management of its affiliated hospitals and its contribution to the health-care sector, said Wang Xinhua, president of the university.

 

Source: CRI Online

The first three high-end medical projects of China-Europe Belt and Road Industry Fund is to be located in Guangzhou Huangpu District, Guangzhou Development District on September 5th 2017. The three projects are Guangzhou Hospital Clinic de Barcelona International Hospital, the Medical School of University of Barcelona - Guangzhou Medical University joint education program, and Pantheon Medical Center. Local residents will benefit from the high-end medical services of international standards in the future.

On the same day, Guangzhou Huangpu District Government and Guangzhou Development District Administrative Committee signed strategic cooperation framework agreement with Guangzhou Medical University, the 5th Hospital Affiliated to Guangzhou Medical University, Hospital Clinic de Barcelona, the Medical School of University of Barcelona, Silver Mountain Capital Limited, and Guangzhou Silver Mountain Global Star Equity Investment Fund Management Company in Guangzhou. According to the agreement, the parties will cooperate to establish Guangzhou Hospital Clinic de Barcelona International Hospital, an international specialty hospital, and also establish one or two high-end international medical centers - Pantheon Medical Center. Guangzhou Hospital Clinic de Barcelona International Hospital and Pantheon Medical Center will be operated and managed by world class healthcare professions and directly connects with overseas commercial insurance companies.

As introduced by Dr. Jose M. Campistol, president of Barcelona Hospital of Spain, this project has been approved by the Spanish Government, and obtained attention and support from the Spanish government. In the future, the collaboration between the international hospital and the 5th Hospital affiliated to Guangzhou Medical University will promote knowledge sharing, exchange programs, and fellow visit from both countries, as well as improving the medical and the technical skill.

Wang Xinhua, president of Guangzhou Medical University said Guangzhou Medical University is now making a positive progress to become a highly academic and world class university. It will take this opportunity to collaborate with the Medical School of Barcelona University and local government and to jointly establish a training program to student. As a result, students from both countries can share and learn from each other not only in school but also in the hospitals between Guangzhou and Barcelona. Such collaboration not only provides training to talents, but also combined with teaching, promote clinical practice and R&D, makes further contributions to training of medical talents in Guangzhou.

 

Source:sina

Press conference of the first Session of Top-ten Classic Sample Enterprises of System Innovation in China (Shanghai) Pilot Free Trade Zone is held on September 28, in Shanghai. In the past four years, Shanghai Free Trade Zone adhered to liberty of minds, taking measures and trying beforehand, focusing on fields like investment, trade, finance and government functions, forming a batch of innovations of basic and core systems. It has promoted over 100 reform innovation achievements around the nation in different fields and levels, striving to lead in comprehensively deepening the reform under new circumstances, accelerating the benchmark and engine of innovation in driving development.
 
In order to display the system dividend the Free Trade Zone brought to enterprises, encouraging more enterprises to participate in and utilize the innovation system of Free Trade Zone, duplicating and promoting innovation policies and experience of Free Trade Zone in larger range, Shanghai Free Trade Zone management committee initiated the first session of evaluation activity of Top-ten Classic Sample Enterprises of System Innovation on March, 2017, establishing platforms to show the system innovation achievements of Free Trade Zone in the past four years, discovering and promoting enterprise operation patterns inside the zone with typical significance, making system dividends of Free Trade Zone benefit more enterprises actively.
 
The evaluation activity lasts for 6 months. The organizing committee conduct large –scale promotion and collection among over 80,000 enterprises in forms of organization recommendation and enterprises’ self-recommendation, going through procedures like media release, enterprise application, field visit, votes by committee of experts, online votes and so on. During this process, the organizing committee had a deep understanding of enterprises’ utilization of innovation policies in Free Trade Zone and the resultant benefits, promoting and popularizing  enterprises’ utilization of innovation policies in Free Trade Zone, eventually selecting the first batch of Classic Sample Enterprises of System Innovation in China (Shanghai) Pilot Free Trade Zone through combination of assessment of expert committee and several times of discussion and research done by organizing committee.
 
In the conference, ten enterprises that won the title of “Top-ten Classic Sample Enterprises of System Innovation” were released:
Top-ten Classic Sample Enterprises of System Innovation are listed as follows in initial letter order: PWC Business Skills Training (Shanghai) Co., Ltd, Shanghai International Hospital Project, Ltd, Shanghai E-Home entertainment Development Company Ltd, Shanghai Shine-Link International Logistics Co., Ltd, Shanghai L’oreal International Trade Co., Ltd, Shanghai Origin Supply Chain Management Co., Ltd, Shanghai FTZ International Culture Investment and Development Co., Ltd, Sony Logistics and Trade (China) Co., Ltd, GE(China) Co., Ltd, Bank of China Shanghai FTZ Branch.
 
Hang Yingwei, Deputy Secretary General of Shanghai Government, governor of Pudong New District, Executive Deputy Director of Shanghai FTZ Management Committee, expressed in his speech that enterprise is the important subject of constructing Pilot Free Trade Zone, whose system innovation has further activated market innovation vitality and motivation of economic development. Until now, there are 48,000 newly registered enterprises in Shanghai Pilot Free Trade Zone, surpassing total amount in the past 20 years before the establishment of Shanghai FTZ. Average amount of registered enterprises is five times of that before the establishment of Shanghai FTZ, with degree of activity of registered enterprises surpassing 80%. In the newly established enterprises, there are 8,781 foreign-invested enterprises, accounting for nearly 20%, which is only 5% in the early stage of the establishment of Shanghai FTZ. Actual contributed foreign capitals are 16.7 billion dollars, nearly twice of the total amount in the past 20 years before the establishment of Shanghai FTZ.
 
Hang Yingwei expressed that selected Top-ten Classic Sample Enterprises of System Innovation and top-six Sample Enterprises of System Innovation are from various districts of Shanghai FTZ, including foreign enterprises, state-owned enterprise and private enterprises, demonstrating the typicality and breakthrough of system innovation in FTZ. The system innovation that are beneficial to enterprises include various fields like investment management, trade facilitation, financial innovation and change of government function, which is the best demonstration that Pilot FTZ’s system innovation achievements have served enterprises and enterprises have actively participated in the construction of Pilot FTZ.
 
Hang Yingwei put forward that in the next step, the construction of Shanghai Pilot Free Trade Zone will keep liberating the minds with the courage to break through and being a god benchmark, comprehensively implementing various targets and tasks in the plan of deepening the reform all-roundly, finding out shortcomings through comparison with the highest international standard from the perspective of enterprises development demand and feeling, creating a more competitive operation environment, providing enterprises with broader stages, more appropriate environment and better services. We believe that enterprises in Pilot FTZ will capture more business opportunities in the hot spot of Pilot FTZ, achieving greater development and creating new glory.
 

&n

German healthcare operator and medical product provider Artemed Group said on Tuesday that it would set up a hospital in the China (Shanghai) Pilot Free Trade Zone. The group signed a framework agreement with Investment Company Silver Mountain Capital, Shanghai Waigaoqiao FTZ 3U-Development Co and Shanghai Waigaoqiao FTZ Healthcare Center on Tuesday. The hospital will be the first fully foreign funded medical institution to be set up in the 28-square-kilometer FTZ.

According to the agreement, the hospital will cover about 10,300 square meters in the pilot zone. The company also plans to set up seven leading medical centers, including a medical image center, a third-party independent diagnostics center, medical training center, research and development center, demonstration center, comprehensive outpatient center and inpatient center in the fields of cardiovascular diseases, muscle and bone diseases, celiac disease and lung diseases. "The hospital will set an example for promoting the implementation of service sector's opening up in the FTZ. Meanwhile, it will help further promote China's medical service level and boost the country's high-end medical industry's development," said Li Yunzhang, deputy general manager of Shanghai Waigaoqiao Group.

The China (Shanghai) Pilot Free Trade Zone was launched in September 2013. It allows foreign investors to develop a series of sectors, including healthcare and medical sector in the zone. The level of opening-up has been further elevated on the 2014 Shanghai Free Trade Zone "negative list", which defines areas that are off-limits for foreign investors in the zone.

In the medical sector, the updated version of the "negative list" has lifted the restrictions on the minimum investment of 20 million yuan ($3.2 million) and the maximum operation period of 20 years.

Zhu Min, deputy director of the China (Shanghai) Pilot Free Trade Zone Administration said: "The 2014 'negative list' further reduces the threshold for foreign investors. Shanghai International Hospital Project in FTZ will undoubtedly set an example for more overseas medical bodies entering into China." Zhu said they are also in talks with other foreign medical intuitions. Chinese media reported that these foreign medical intuitions include hospitals from Australia and Japan, for ventures in the fields of tumor and postoperative recovery treatment.

Many investors have expressed interest in opening hospitals in the Shanghai FTZ, as they see huge growth potential in China's healthcare market, said Zhou Mingren, vice-president of Shanghai Landseed International Hospital, the first totally Taiwan-invested hospital on the mainland, which opened for business in 2012.

In recent years, China has been steadily loosening restrictions for overseas investors in the medical sector. According to a document on speeding up the development of the medical sector by social capital, released by the National Health and Family Planning Commission at the end of 2013, the areas for investors from Hong Kong, Macao and Taiwan to establish wholly owned hospitals have expanded to all prefecture-level cities on the mainland.

Other qualified overseas investors can develop wholly-owned medical units in the Shanghai free trade zone and other special zones, it said.

Rainer Salfeld, executive director of Artemed said the company welcomes the considerable efforts taken by the government to promote people's health in China. "We will support China's healthcare reform and introduce advanced medical knowledge, equipment and management experiences," he said. The Artemed Group operates eight hospitals and five elderly-care centers in Germany, serving over 50,000 inpatients and 150,000 outpatients every year.

 

 

 Reprinted from Xinhua News